Literature DB >> 33857288

PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress.

James S Chavez1, Jennifer L Rabe1, Dirk Loeffler2, Kelly C Higa3, Giovanny Hernandez1, Taylor S Mills1,4, Nouraiz Ahmed2, Rachel L Gessner1, Zhonghe Ke1, Beau M Idler1, Katia E Niño1, Hyunmin Kim5, Jason R Myers6, Brett M Stevens1, Pavel Davizon-Castillo7, Craig T Jordan1, Hideaki Nakajima8, John Ashton6, Robert S Welner9, Timm Schroeder2, James DeGregori1,3,4,7, Eric M Pietras1,4.   

Abstract

Hematopoietic stem cells (HSCs) are capable of entering the cell cycle to replenish the blood system in response to inflammatory cues; however, excessive proliferation in response to chronic inflammation can lead to either HSC attrition or expansion. The mechanism(s) that limit HSC proliferation and expansion triggered by inflammatory signals are poorly defined. Here, we show that long-term HSCs (HSCLT) rapidly repress protein synthesis and cell cycle genes following treatment with the proinflammatory cytokine interleukin (IL)-1. This gene program is associated with activation of the transcription factor PU.1 and direct PU.1 binding at repressed target genes. Notably, PU.1 is required to repress cell cycle and protein synthesis genes, and IL-1 exposure triggers aberrant protein synthesis and cell cycle activity in PU.1-deficient HSCs. These features are associated with expansion of phenotypic PU.1-deficient HSCs. Thus, we identify a PU.1-dependent mechanism triggered by innate immune stimulation that limits HSC proliferation and pool size. These findings provide insight into how HSCs maintain homeostasis during inflammatory stress.
© 2021 Chavez et al.

Entities:  

Year:  2021        PMID: 33857288     DOI: 10.1084/jem.20201169

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks.

Authors:  Kartika Venugopal; Yang Feng; Pawel Nowialis; Huanzhou Xu; Daniil E Shabashvili; Cassandra M Berntsen; Prabhjot Kaur; Kathryn I Krajcik; Christina Taragjini; Zachary Zaroogian; Heidi L Casellas Román; Luisa M Posada; Chamara Gunaratne; Jianping Li; Daphné Dupéré-Richer; Richard L Bennett; Santhi Pondugula; Alberto Riva; Christopher R Cogle; Rene Opavsky; Brian K Law; Sumita Bhaduri-McIntosh; Stefan Kubicek; Philipp B Staber; Jonathan D Licht; Jonathan E Bird; Olga A Guryanova
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 12.531

2.  Expansion of Quiescent Hematopoietic Stem Cells under Stress and Nonstress Conditions in Mice.

Authors:  Sen Zhang; Yao Ma; Lisha Wang; Xialin Li; Yan Dong; Jinhong Wang; Tao Cheng; Fang Dong; Hideo Ema
Journal:  Stem Cell Rev Rep       Date:  2022-04-30       Impact factor: 6.692

3.  Reduced PU.1 Expression Collaborates with Tet2 Loss to Trigger Myeloid Leukemogenesis.

Authors:  Wolfgang E Schleicher; Eric M Pietras
Journal:  Blood Cancer Discov       Date:  2022-09-06

4.  IL-18R-mediated HSC quiescence and MLKL-dependent cell death limit hematopoiesis during infection-induced shock.

Authors:  Jennifer E Howard; Julianne N P Smith; Gabrielle Fredman; Katherine C MacNamara
Journal:  Stem Cell Reports       Date:  2021-11-18       Impact factor: 7.765

Review 5.  Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies.

Authors:  Virginia Camacho; Valeriya Kuznetsova; Robert S Welner
Journal:  Front Immunol       Date:  2021-11-03       Impact factor: 7.561

6.  PU.1 Expression Defines Distinct Functional Activities in the Phenotypic HSC Compartment of a Murine Inflammatory Stress Model.

Authors:  James S Chavez; Jennifer L Rabe; Giovanny Hernandez; Taylor S Mills; Katia E Niño; Pavel Davizon-Castillo; Eric M Pietras
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

7.  Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles.

Authors:  Stefania Trino; Ilaria Laurenzana; Daniela Lamorte; Giovanni Calice; Angelo De Stradis; Michele Santodirocco; Alessandro Sgambato; Antonella Caivano; Luciana De Luca
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

8.  Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.

Authors:  Nouraiz Ahmed; Martin Etzrodt; Philip Dettinger; Tobias Kull; Dirk Loeffler; Philipp S Hoppe; James S Chavez; Yang Zhang; Germán Camargo Ortega; Oliver Hilsenbeck; Hideaki Nakajima; Eric M Pietras; Timm Schroeder
Journal:  J Exp Med       Date:  2021-11-24       Impact factor: 17.579

Review 9.  Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection.

Authors:  Eric M Pietras; Markus G Manz; Francisco Caiado
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 14.307

10.  Hydroxycarbamide effects on DNA methylation and gene expression in myeloproliferative neoplasms.

Authors:  Stephania Contreras Castillo; Bertille Montibus; Azucena Rocha; Will Duke; Ferdinand von Meyenn; Donal McLornan; Claire Harrison; Ann Mullally; Reiner Schulz; Rebecca J Oakey
Journal:  Genome Res       Date:  2021-07-09       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.